← Every company
Bristol-Myers Squibb Co Planned Sales
Before an insider at Bristol-Myers Squibb Co can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
BMY insider trades →Notices on file
1
Insiders
1
Shares noticed
3.8K
permission to sell, not sales
Estimated value
$250K
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| A Haller Gottsch JuliaDirector2026-11-053.8K sh<0.01% | $250K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on BMY
Company overviewEverything on BMY in one place, with the price.SEC filingsWhat BMY's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat BMY's own officers and directors buy and sell.Who owns itEvery manager reporting a position in BMY.Funds holding itWhich funds and ETFs hold BMY, and how big a bet.LobbyingWhat BMY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BMY's account, and who they worked for.Federal contractsWhat federal agencies pay BMY.PatentsWhat BMY is filing at the patent office.